News

Artificial intelligence, engineering biology and quantum technologies: highlight notice

Artificial intelligence, engineering biology and quantum technologies: highlight notice

Apply for funding for the application of artificial intelligence (AI), engineering biology, and quantum technologies in biomedical research and development. You must be based at a UK research organisation eligible for MRC funding. You can get funding through any grants from MRC responsive mode or translation funding opportunities.

Funding news

Apply for funding for the application of artificial intelligence (AI), engineering biology, and quantum technologies in biomedical research and development.

You must be based at a UK research organisation eligible for MRC funding.

You can get funding through any grants from MRC responsive mode or translation funding opportunities.

You should apply through the existing funding opportunity that is most relevant to your science area and career stage.

We will usually fund up to 80% of your project’s full economic cost.

This highlight notice will be open from 1 April 2024 to 31 March 2025. Applications submitted in this window will be considered for this highlight opportunity. For individual application closing dates refer to the relevant MRC funding opportunity.

Aim

UK Research and Innovation (UKRI) recognises the strategic importance to the UK of five critical technologies:

  • future telecommunications
  • semiconductors
  • AI
  • engineering biology
  • quantum technologies

These have been selected for their ability to build strategic advantage, create opportunities for growth, and capitalise on existing UK strengths.

Scope

During the highlight period MRC particularly welcomes applications from teams that are applying AI, engineering biology or quantum technologies, to better enable them to meet relevant MRC board and panel and cross-cutting themes.

Artificial intelligence (AI)

AI is considered here to be machines that perform tasks normally performed by human intelligence, especially when the machines learn from data how to do those tasks.

You should be clear on the biomedical research challenge to be addressed, how use of AI will deliver impact beyond incremental optimisation of current systems, and where, if applicable complementarity exists with UKRI strategies (for example Transforming our World with AI) and existing investments in the same area (for example Responsible AI UK).

You should also consider, where applicable, how the AI tools developed will act as a platform for future applications in biomedical research, for example underpinning future research or infrastructure, including through generalizable approaches.

Engineering biology

The design and fabrication of biological components and systems, from modifications of natural systems through to artificial biology, in order to enhance our understanding of human health and disease or in the development of novel diagnostics, therapeutics and vaccines

Quantum technologies

Applications focused on utilisation of quantum sensing technologies aimed at improving diagnostics for early detection of disease, biomarker identification and increasing understanding of physiological systems in diseased states.

You should refer to this highlight notice and the critical technology in your application summary.

You can search the UKRI funding finder for the following funding opportunities where this highlight notice is relevant:

NEWS​

Related News

CSG reinforces its commitment to innovation, competitiveness and sustainability in 2025

21 Jan 2025
In this news piece, readers will learn about the Cluster Saúde de Galicia's renewed strategic focus for 2025, aimed at positioning Galicia as a global...

NOTRE Project update: New Good Practices Identified

20 Jan 2025
Learn about the latest updates on NOTRE: 18 new good practices linked to the project.

Invest4Health Open Call

16 Jan 2025
Invest4Health has launched its Open Call, aimed at supporting regional test-beds in building their competence and capacity on using novel business, fi...

Study visit and follow-up meeting in San Sebastian

16 Jan 2025
As part of Semester 3 of the NOTRE project, the follow-up meeting in San Sebastián on April 23-24 brought together partners to assess progress, explor...

The NanoBio4Can Postdoctoral Programme’s 2nd Open Call is opening soon!

16 Jan 2025
Izmir Biomedicine and Genome Center is thrilled to announce that the 2nd Call for the NanoBio4Can MSCA COFUND Programme will soon be open for applicat...

Switzerland – DayOne Basel Ecosystem is ECHAlliance Ecosystem of the Month – January

15 Jan 2025
This month we are featuring our Switzerland - DayOne Basel Ecosystem as our Ecosystem of the Month.

Become a member

Join ECHAlliance to amplify your organisation’s message, grow your networks, connect with innovators and collaborate globally.
 
First name *
Last Name *
Email Address *
Country *
Position *
First name *
Last Name *
Email Address *
Country *
Position *